Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 03.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 233,85 300 | 233,85 | 300 | 28,314799 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 233,85 250 | 233,85 | 250 | 6,928999 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 233,85 260 | 233,85 | 260 | 11,206159 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 233,85 250 | 233,85 | 250 | 6,928999 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 233,85 332 | 233,85 | 332 | 42,001711 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 233,85 275 | 233,85 | 275 | 17,621899 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 233,85 275 | 233,85 | 275 | 17,621899 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 233,85 250 | 233,85 | 250 | 6,928999 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 233,85 275 | 233,85 | 275 | 17,621899 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 233,85 332 | 233,85 | 332 | 42,001711 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 233,85 332 | 233,85 | 332 | 42,001711 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 233,85 390 | 233,85 | 390 | 66,809239 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 233,85 436 | 233,85 | 436 | 86,484175 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 233,85 415 | 233,85 | 415 | 77,502139 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 233,85 390 | 233,85 | 390 | 66,809239 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 233,85 390 | 233,85 | 390 | 66,809239 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 233,85 415 | 233,85 | 415 | 77,502139 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 233,85 390 | 233,85 | 390 | 66,809239 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 233,85 360 | 233,85 | 360 | 53,977759 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 233,85 295 | 233,85 | 295 | 26,176219 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 233,85 295 | 233,85 | 295 | 26,176219 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 233,85 350 | 233,85 | 350 | 49,700599 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 233,85 352 | 233,85 | 352 | 50,556031 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 233,85 295 | 233,85 | 295 | 26,176219 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 233,85 270 | 233,85 | 270 | 15,483319 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 233,85 375 | 233,85 | 375 | 60,393499 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 233,85 315 | 233,85 | 315 | 34,730539 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 233,85 353 | 233,85 | 353 | 50,983747 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 233,85 500 | 233,85 | 500 | 113,857998 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 233,85 500 | 233,85 | 500 | 113,857998 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 233,85 290 | 233,85 | 290 | 24,037639 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 233,85 375 | 233,85 | 375 | 60,393499 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 233,85 391 | 233,85 | 391 | 67,236955 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 233,85 | 233,85 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 233,85 315 | 233,85 | 315 | 34,730539 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 233,85 400 | 233,85 | 400 | 71,086399 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 475 | 233,85 | 475 | 103,165098 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 233,85 600 | 233,85 | 600 | 156,629598 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 233,85 | 233,85 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 233,85 315 | 233,85 | 315 | 34,730539 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 233,85 315 | 233,85 | 315 | 34,730539 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 600 | 233,85 | 600 | 156,629598 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 233,85 391 | 233,85 | 391 | 67,236955 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 233,85 290 | 233,85 | 290 | 24,037639 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 233,85 500 | 233,85 | 500 | 113,857998 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 233,85 500 | 233,85 | 500 | 113,857998 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 233,85 290 | 233,85 | 290 | 24,037639 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 233,85 315 | 233,85 | 315 | 34,730539 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 233,85 600 | 233,85 | 600 | 156,629598 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 233,85 290 | 233,85 | 290 | 24,037639 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 233,85 600 | 233,85 | 600 | 156,629598 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 233,85 340 | 233,85 | 340 | 45,423439 | UBS | ||
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 233,85 540 | 233,85 | 540 | 130,966638 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 233,85 500 | 233,85 | 500 | 113,857998 | JPMORGAN |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 26.03.2026 | Ordentliche Hauptversammlung Novo Nordisk A/S: Annual General Meeting 2026 | Novo Nordisk A/S: Annual General Meeting 2026 |
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M